(CBOE: CLL )

1,658.06 USD +16.95 (+1.03%)

Daily Price Updated: 4:15 PM EDT, Aug 23, 2024 Add to My Watchlist

Index Value

Price	1,658.06
Volume	0
Open	1,649.13
Prev. Close	1,641.11
Change	+16.95
% Change	+1.03%
Today's Range	1,645.16 - 1,660.24
52wk Range	1,272.85 - 1,668.03

Chart for (: )

1 Week 1 Month 3 Month 1 Year 3 Year

Top News

BiocurePharm, Korea (BPK) Signs MOU With Symbasis GmbH to Develop CAR-T Therapy for Chronic Lymphocyte Leukemia (CLL)

January 04, 2021

BeiGene Reports BTK Inhibitor Posts Better Results than the Competition

June 11, 2021

Beijing 's BeiGene presented positive interim results from Phase III trial that compared its BTK candidate to AbbVie's Imbruvica (ibrutinib). In the trial, BeiGene's Brukinsa® (zanubrutinib) produced a...

Performance

YTD	+17.13%	+17.13%
1 Month	+3.53%	+3.53%
3 Month	+5.80%	+5.80%
6 Month	+10.06%	+10.06%
1 Year	+25.19%	+25.19%

More News

InnoCare Approved to Launch BTK Inhibitor for Three Indications in China

December 31, 2020

Fed Holds But Signals Hawkish Path Ahead, Treasury Yields Rise: The Week In The Markets

September 22, 2023

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.